ClinVar Miner

Submissions for variant NM_032237.5(POMK):c.773A>G (p.Gln258Arg) (rs397509386)

Minimum review status: Collection method:
Minimum conflict level:
ClinVar version:
Total submissions: 2
Download table as spreadsheet
Submitter RCV SCV Clinical significance Condition Last evaluated Review status Method Comment
Invitae RCV001068653 SCV001233778 uncertain significance Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type a, 12; Muscular dystrophy-dystroglycanopathy (limb-girdle), type c, 12 2019-06-24 criteria provided, single submitter clinical testing This sequence change replaces glutamine with arginine at codon 258 of the POMK protein (p.Gln258Arg). The glutamine residue is highly conserved and there is a small physicochemical difference between glutamine and arginine. This variant is not present in population databases (ExAC no frequency). This variant has been observed in combination with another POMK variant in an individual affected with Walker-Warburg syndrome (PMID: 23519211). ClinVar contains an entry for this variant (Variation ID: 50611). This variant has been reported to affect POMK protein function (PMID: 23519211). In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance.
OMIM RCV000043556 SCV000071333 pathogenic Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type a, 12 2013-04-26 no assertion criteria provided literature only

The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. Neither the University of Utah nor the National Institutes of Health independently verfies the submitted information. If you have questions about the information contained on this website, please see a health care professional.